Λογότυπο www.galinos.gr Beta
 

Ιατροφαρμακευτική πληροφόρηση για τον επαγγελματία υγείας

Φάρμακα Δραστικές ουσίες Συμπληρώματα διατροφής Έλεγχος συγχορήγησης Νόσοι ICD-10
Κλαύδιος Γαληνός
Είσοδος χρηστών
Όνομα χρήστη
Συνθηματικό
Εικονίδιο Είσοδος χρήστη
Εικονίδιο Δωρεάν εγγραφή
Εικονίδιο Ανανέωση συνθηματικού

Ακολουθήστε μας Λογότυπο Facebook Λογότυπο Twitter

Αναζήτηση σε 63811 καταχωρήσεις
Εικονίδιο αναζήτησης

Βιβλιογραφική αναφορά

Προτάσεις

SPC, UK: Pregnyl 5000IU (2012)

Εκδότης

Εκδότης Merck Sharp & Dohme Limited
Διεύθυνση Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Σφάλμα Για την προβολή της πλήρους καταχώρησης χρειάζεται να έχετε συνδρομή σε ισχύ (αγορά συνδρομής).
Ολοκληρώνοντας τη διαδικασία δωρεάν εγγραφής θα αποκτήσετε, χωρίς καμία δέσμευση εκ μέρους σας, συνδρομή διάρκειας 30 ημερών.

Περιεχόμενα

Name of the medicinal product

Pregnyl 5000 I.U. Powder for solution for injection.

Qualitative and quantitative composition

Pregnyl consists of a freeze-dried powder for injection. The active ingredient [human chorionic gonadotrophin ...

Pharmaceutical form

Powder for solution for injection. The powder is a white, dry powder or cake.

Therapeutic indications

In the female Sterility due to the absence of follicle-ripening or ovulation. In combination with FSH ...

Posology and method of administration

Dosage In the female Sterility due to the absence of follicle-ripening or ovulation: 5,000–10,000 IU ...

Contraindications

Hypersensitivity to human gonadotrophins or any of the excipients of Pregnyl. Presence of uncontrolled ...

Special warnings and precautions for use

In the female Since infertile women undergoing assisted reproduction, and particularly IVF, often have ...

Interaction with other medicinal products and other forms of interaction

No interaction studies have been performed; interactions with commonly used medicinal products can therefore ...

Pregnancy and lactation

Not applicable.

Effects on ability to drive and use machines

As far as known Pregnyl has no influence on the ability to drive and use machines.

Undesirable effects

Frequency is unknown for all undesirable effects described below (cannot be determined with available ...

Overdose

The toxicity of human chorionic gonadotrophic hormone is very low. However, too high a dose may lead ...

Pharmacodynamic properties

Pharmacotherapeutic group: gonadotrophins ATC code: G03GA01 Pregnyl is a preparation of human chorionic ...

Pharmacokinetic properties

In a study performed in healthy male subjects, maximal hCG plasma levels were reached after a single ...

Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included ...

List of excipients

Powder for injection contains: Carmellose sodium Mannitol (E421) Disodium phosphate (anhydrous) Sodium ...

Incompatibilities

In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal ...

Shelf life

36 months.

Special precautions for storage

Store at 2 to 8°C. Do not freeze. Keep the ampoules in the outer carton to protect from light.

Nature and contents of container

2ml ampoule containing freeze-dried powder with 1ml ampoule of solvent (sodium chloride 9mg/ml). Pregnyl ...

Special precautions for disposal and other handling

Pregnyl should be reconstituted with the solvent provided. Do not use if the solution contains particles ...

Marketing authorization holder

Organon Laboratories Limited Cambridge Science Park Milton Road Cambridge CB4 0FL U.K.

Marketing authorization number(s)

0065/5079R

Date of first authorization / renewal of the authorization

24th February 1991/25th March 2003

Date of revision of the text

4th January 2012
Απαγορεύεται η αναπαραγωγή και αναδιανομή. Το έργο επεξεργασίας των παραπάνω πληροφοριών αποτελεί πνευματική ιδιοκτησία της Ergobyte Πληροφορική Α.Ε. και προστατεύεται από τη νομοθεσία περί πνευματικών δικαιωμάτων.